Roche’s head of pharma joins Gilead as CEORoche’s pharmaceuticals head Daniel O’Day is leaving to join Gilead as its new chief executive., the Financial Times said on Monday.
AZN partners with Cancer Research UKAstraZeneca is working with Cancer Research UK to harness big data and genetics and accelerate the development of new medicines, The Times said on Tuesday.
UK pharma companies failing to respond to code of practice complaintsThe Times on Wednesday reported on a warning from the UK’s Prescription Medicines Code of Practice Authority (PMCPA) that pharma companies are failing to respond to complaints with “complete and accurate information”.
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.